Tumors on the lungs need to be clearly defined as benign or malignant, and benign ones have a long survival time. If it is malignant, it depends on the stage and treatment effect, the survival time, from a few months to more than five years, even long-term survival is possible. Benign tumors of the lung are generally rare to see recurrence and metastasis after surgical resection and have a longer survival. For malignant tumors, which are usually called lung cancer, the survival time varies greatly according to the pathological type, clinical tumor stage and tumor treatment methods: if the tumor is found at an advanced stage, the chance of treatment is lost, and the survival time is not too long, from a few months to a few years; if it is found in time, through regular treatment means, the five-year survival rate of early lung cancer reaches more than 90%, and the prognosis is good, and the survival of 20 years is also possible; if If the tumor is found in the middle or late stage, the treatment effect will be poor and the five-year survival rate will be greatly reduced. If the tumor is metastatic, basically the cancer has reached an advanced stage and the chance of surgery has been lost, so it needs to be treated by a combination of radiotherapy, chemotherapy, targeted therapy, etc. The response or side effects of these adjuvant treatments vary greatly, but overall, the survival time is not long. To sum up, lung tumors need to look at the benignity and malignancy, followed by whether they are primary or secondary. Survival can range from a few months to decades. Early malignant tumors are treated well and have a high five-year survival rate, while mid- to late-stage results are relatively worse and worse and survival times are substantially reduced.